Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Covid 19 IS the promotor
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1577)
•••
Comment by Pandoraon Aug 23, 2020 1:59pm
189 Views
Post# 31443448

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Covid 19 IS the promotor

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Covid 19 IS the promotor
O.T. re TLT but Covid related:(suit yourself):

Trump is supposed to make a significant announcement this afternoon(6 p.m. EDT) regarding therapeutics. Is he likely to just be pumping Remdesivir and Dexamethasone again or are they finally moving on to something else. Testing and vaccines are getting all the press. As an old guy I would much prefer a therapeutic that will keep me alive long enough to have to be tested or vaccinated. Just a personal preference and opinion.:-))

You can check CYDY but that is just wishful thinking on my part. Others are mentioning RLFTF or a long shot AGN which are both lung injury meds as well.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities